Lilly Eli Co (LLY)

07:45 AM

Eli Lilly launches its blockbuster weight loss drug Mounjaro in India - Mint

07:45 AM

03:42 AM

Eli Lilly Shares Are Up Today: What's Going On? - Benzinga

03:42 AM

02:23 AM

Eli Lilly’s diabetes and weight-loss drug Mounjaro debuts in India - Investing.com Australia

02:23 AM

02:08 AM

Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market - Reuters

02:08 AM

12:08 PM

Lilly's weight-loss drug launch in India to energize rivals eyeing mega market - Reuters

12:08 PM

10:32 AM

Weight-loss drug Mounjaro now available in India: All you need to know - Business Standard

10:32 AM

10:31 AM

Eli Lilly beats Novo Nordisk to launch weight-loss drug Mounjaro in India, at $50 for 5 mg vial - Bilyonaryo Business News

10:31 AM

10:17 AM

Behind the Scenes of Eli Lilly's Latest Options Trends - Benzinga

10:17 AM

09:20 AM

Eli Lilly launches weight loss drug in India (LLY:NYSE) - Seeking Alpha

09:20 AM

09:04 AM

Eli Lilly Introduces Mounjaro Single-Dose Vial for Diabetes and Obesity - SMEStreet

09:04 AM

08:39 AM

Eli Lilly launches weight-loss drug Mounjaro in India at $50 for 5 mg vial, beating Novo Nordisk - PharmaLive

08:39 AM

08:14 AM

Indias First Weight-Loss Drug Arrives: Eli Lilly Launches Mounjaro; Know How Much It Will Cost You - Free Press Journal

08:14 AM

07:36 AM

India gets first weight-loss drug as Eli Lilly launches Mounjaro - Gulf News

07:36 AM

07:19 AM

1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street - The Motley Fool

07:19 AM

07:03 AM

Eli Lilly beats Novo Nordisk to launch weight-loss drug Mounjaro in India - 코리아타임스

07:03 AM

06:49 AM

Eli Lilly launches drug Mounjaro in India for obesity, type 2 diabetes treatment - The Sen Times

06:49 AM

05:29 AM

Eli Lilly’s weight loss drug launches in India: Here are 4 things to know about Mounjaro - The Indian Express

05:29 AM

05:27 AM

Eli Lilly launches weight-loss drug Mounjaro in India at Rs. 3,500 after drug regulator approval - The Economic Times

05:27 AM

05:25 AM

5 Reasons It's Not Too Late to Buy Eli Lilly Stock - The Motley Fool

05:25 AM

05:15 AM

Eli Lilly First to Launch Weight Loss Drug in Obesity-Hit India - Bloomberg

05:15 AM

04:40 AM

Lilly Says Mounjaro 2.5 Mg Vial Priced At 3,500 Rupees In India -March 20, 2025 at 04:35 am EDT - Marketscreener.com

04:40 AM

03:44 AM

Eli Lilly launches blockbuster anti-obesity drug Mounjaro in India. Price here - Business Standard

03:44 AM

03:44 AM

Eli Lilly launches diabetes-obesity management drug Mounjaro in India - Business Standard

03:44 AM

03:23 AM

Lilly India Launches Mounjaro, Offering New Option For Treatment Of Obesity And Type 2 Diabetes - Marketscreener.com

03:23 AM

Mar 19, 2025

Immunology Drugs Market Key Players AnalysisEli Lilly, AbbVie Inc, F.Hoffmann-La roche Ltd, Amgen Inc, Pfizer. - openPR

Mar 19, 2025

Mar 18, 2025

HHS Seeks Early Win Over Lilly, Novartis, BMS In Rebate Row - Law360

Mar 18, 2025

Mar 18, 2025

Eli Lilly And Company (LLY): Among Stocks to Buy That May Be Splitting Soon - Insider Monkey

Mar 18, 2025

Mar 18, 2025

Is Eli Lilly and Company (LLY) the Best Diabetes Stock to Buy According to Billionaires? - Insider Monkey

Mar 18, 2025

Mar 18, 2025

Eli Lilly’s $3B Expansion Gets Green Light in Kenosha County - Civic Media

Mar 18, 2025

Mar 18, 2025

Eli Lilly stock holds strong on Outperform rating by Bernstein - Investing.com

Mar 18, 2025

Mar 18, 2025

Jim Cramer Says Eli Lilly And Co (LLY) Sellers Are ‘Uninformed’ - Insider Monkey

Mar 18, 2025

Mar 17, 2025

Eli Lilly wins final approval for $3B expansion in Pleasant Prairie - The Business Journals

Mar 17, 2025

Mar 17, 2025

Eli Lilly, Pfizer Back Teva Fight of US Drug Price Negotiations - Bloomberg Law

Mar 17, 2025

Mar 17, 2025

Eli Lilly: A Safe Harbor Amid Market Volatility (NYSE:LLY) - Seeking Alpha

Mar 17, 2025

Mar 17, 2025

Positive Outlook for Eli Lilly & Co. Amid FDA Support and Strong Revenue Projections - TipRanks

Mar 17, 2025

Mar 17, 2025

Citi sees positive read-through to Lilly shares on FDA GLP-1 statement - TipRanks

Mar 17, 2025

Mar 17, 2025

This Is What Whales Are Betting On Eli Lilly - Benzinga

Mar 17, 2025

Mar 17, 2025

Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Mar 17, 2025

Mar 17, 2025

Pharmaceutical Giants Like J&J, Merck, and Eli Lilly Accelerate - openPR

Mar 17, 2025

Mar 17, 2025

How Eli Lilly is Shaping Kinsale and Ireland's Economic LandscapeNews and Statistics - IndexBox, Inc.

Mar 17, 2025

Mar 16, 2025

Is Eli Lilly and Company (LLY) the Best Quality Stock to Invest in Now? - MSN

Mar 16, 2025

Mar 16, 2025

Jim Cramer Says: “Keep an Eye on Eli Lilly and Company (LLY)” - Insider Monkey

Mar 16, 2025

Mar 16, 2025

Slow NHS puts investment at risk, warns ‘King Kong’ weight-loss jab maker - The Telegraph

Mar 16, 2025

Mar 15, 2025

Tesla's problems, Eli Lilly's weight loss pill, and egg prices surge: Business news roundup - Yahoo Finance

Mar 15, 2025

Mar 14, 2025

Eli Lilly snaps six days of losses - Seeking Alpha

Mar 14, 2025

Mar 14, 2025

Eli Lilly Reverses Its Recent Run On Market Malaise. Is It A Sell? - Investor's Business Daily

Mar 14, 2025

Mar 14, 2025

Senators expand probe of Pfizer, Lilly DTC platforms to include telehealth provider partners - FiercePharma

Mar 14, 2025

Mar 14, 2025

Altimmune to study obesity drug in alcohol use disorder, following Eli Lilly - STAT

Mar 14, 2025

Mar 14, 2025

An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup - Yahoo Finance

Mar 14, 2025

Mar 13, 2025

Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - GlobeNewswire Inc.

Mar 13, 2025